TNF-α blocks the insulin signaling pathway by inhibiting tyrosine phosphorylation of IRS-1, thereby downregulating GLUT4 expression in adipocytes and elevating HOMA-IR indices; this also causes the inhibition of lipocalin production, resulting in the formation of a pathological cycle of insulin resistance (82–85). The gene discussed is INS; the disease is Insulin resistance.